| Pulmonary Cell News 6.15 April 20, 2017 | |
|
|
|
|
TOP STORYIron loading caused cell proliferation in cancer cell lines, which were less able to regulate IREB2 expression than primary bronchial epithelial cells. Iron chelation resulted in a return of proliferation rates to baseline levels; knockdown of IREB2 had a similar effect. [Eur Respir J] Abstract |
|
|
|
|
PUBLICATIONS(Ranked by impact factor of the journal)Potential Toxicity of Polymyxins in Human Lung Epithelial Cells Researchers investigated the effect of polymyxins on human lung epithelial cells (A549). The viability of A549 cells was examined after treatment with polymyxins using flow cytometry. [Antimicrob Agents Chemother] Abstract Scientists hypothesized that airway epithelial ion transport is a target of fume toxicity, and investigated the effects of fume particulates from manual metal arc-stainless steel and gas metal arc-mild steel on ion transport in normal human bronchial epithelium cultured in air-interface. [Toxicol Appl Pharmacol] Abstract Human bronchial epithelial cells (BEAS-2B) were used to investigate the toxic effect and gene expression changes induced by PM2.5 collected from Beijing, China, based on microarray and following bioinformatic analyses. [Toxicol In Vitro] Abstract Resveratrol Reduces the Apoptosis Induced by Cigarette Smoke Extract by Upregulating MFN2 The authors investigated the effect of resveratrol (RSV) on cigarette smoke extract (CSE)-induced cell apoptosis and mitochondrial dysfunction in vitro, as well as changes in the MFN2 expression level. Cultured human bronchial epithelial cells were initially treated with CSE to induce apoptosis, followed by incubation either with or without RSV. [PLoS One] Full Article LUNG CANCERInvestigators report that gain-of-function (GOF) p53 induced tumorigenicity through simultaneous activation of key oncogenic pathways including those controlling putative tumor-initiating cell functions. They determined that in cells expressing p53-R273H, GOF p53 simultaneously up-regulated genes from multiple signaling pathways by recognizing promoters containing distinct transcription factor binding sites. [Mol Oncol] Abstract | Full Article Researchers found that the carbonic anhydrase IX-triptolide-liposomes (CA IX-TPL-Lips) significantly improved the cellular uptake efficiency in both CA IX-positive human non-small cell lung cancer cells (A549) and A549 tumor spheroids, resulting in the efficient cell killing compared with free TPL and non-targeted TPL-Lips. [Sci Rep] Full Article p16 upregulation did not induce cellular senescence but rather promoted survival of RB1-deficient lung epithelial progenitor cells. Mechanistic studies showed that p16 protects RB1-deficient cells from DNA damage. Consequently, additional loss of p16 led to genetic instability and increased susceptibility to cellular immortalization and transformation. [Oncogenesis] Full Article Scientists investigated the correlation between histone acetylation and Notch1 expression in lung carcinoma. Using chromatin immunoprecipitation assay, they measured the level of acetylated histone H3 around the promoter region of Notch1 in small-cell lung carcinoma (SCLC) and non-SCLC cells. [Lab Invest] Abstract Nrf2 Promotes Progression of Non-Small Cell Lung Cancer through Activating Autophagy Elevated NFE2-related factor 2 (Nrf2) expression promoted non-small cell lung cancer progression, enhancing the escape of tumor cells from apoptosis in vivo and in vitro. Double staining with Annexin V-APC and 7-AAD showed that the proportions of apoptotic cells in 95D-Nrf2 cells were gradually increased after the addition of 3-MA. [Cell Cycle] Abstract The protein and mRNA levels of PFN2 in human bronchial epithelial cell line 16HBE and three non-small cell lung cancer (NSCLC) cell lines A549, NCI-H520 and 95D were assessed. The gain-of-function and loss-of-function experiments of PFN2 were performed in 95D cells. PFN2 was upregulated in three NSCLC cell lines, and the highest in 95D cell line. [Oncol Rep] Abstract |
|
|
|
|
REVIEWSThe authors review the most relevant findings of clinical trials investigating drugs targeting fibroblast growth factor receptor (FGFR) pathway: such as FGFR tyrosine kinase inhibitors, FGFR monoclonal antibodies and FGF ligand traps in non-small cell lung cancer patients. [Expert Opin Investig Drugs] Abstract Visit our reviews page to see a complete list of reviews in the pulmonary cell research field. |
|
|
|
|
INDUSTRY NEWSCellular Dynamics International Signs Distribution Deal with STEMCELL Technologies Cellular Dynamics International announced it has signed a distribution agreement with STEMCELL Technologies, a world leader in iPS cell culture media. [STEMCELL Technologies Inc.] Press Release Boehringer Ingelheim Phase III Study Now Enrolling Patients with Progressive Fibrosing Lung Diseases Boehringer Ingelheim announced that the first patient has been enrolled in the progressive fibrosing interstital lung disease (PF-ILD) trial. This study investigated the efficacy and safety of nintedanib in a range of progressive fibrosing lung conditions other than idiopathic pulmonary fibrosis. [Boehringer Ingelheim GmbH] Press Release AbbVie announced that two Phase III studies evaluating veliparib, an investigational, oral poly (adenosine diphosphate [ADP]-ribose) polymerase inhibitor did not meet their primary endpoints. The studies evaluated veliparib in combination with the chemotherapy regimen carboplatin and paclitaxel in patients with squamous non-small cell lung cancer and triple negative breast cancer. [AbbVie Inc.] Press Release OncoMed’s Phase II Trial of Tarextumab in Small Cell Lung Cancer Does Not Meet Endpoints OncoMed Pharmaceuticals, Inc. reported top-line results from the company’s randomized 145-patient Phase II PINNACLE clinical trial of tarextumab in combination with etoposide plus either cisplatin or carboplatin chemotherapy in previously untreated patients with extensive-stage small cell lung cancer. [OncoMed Pharmaceuticals, Inc.] Press Release FDA Confirms Prometic’s PBI-4050 IPF Clinical Trial Design Prometic Life Sciences Inc. announced that it has received concurrence from the US Food and Drug Administration (FDA) on the design of the first of its PBI-4050’s planned Phase II/III clinical trials for idiopathic pulmonary fibrosis (IPF) based on the efficacy data generated in the recently completed 40 patient Phase II open-label study. [Prometic Life Sciences Inc.] Press Release | |
|
|
|
POLICY NEWSWhat a Surprise General Election Could Mean for HE Theresa May’s plan to hold a general election on the 8th of June raises implications for universities in terms of whether the Higher Education and Research Bill can continue, the vote’s status as the “Brexit election”, and the expected emergence of Labor’s plan to scrap tuition fees. [Times Higher Education] Editorial French-Election Fears Unite Scientists in Defense of Liberal Democracy For scientists in France, the presidential contest is often a chance to debate research and science-related issues. When Nicolas Sarkozy was elected a decade ago, for example, university reforms and environmental policy featured prominently in the campaigns. But this time, science has barely been mentioned — elbowed out by political scandals and the rise of Marine Le Pen’s far-right Front National party. [Nature News] Editorial Republican Scientists Negotiate the Trump Era Conservative academics face a growing tension between their politics and the liberal atmosphere on many US campuses. [Nature News] Editorial
|
|
EVENTSNEW ISSCR Annual Meeting 2017 Visit our events page to see a complete list of events in the community.
|
|
JOB OPPORTUNITIESNEW Tenure Track Positions – Translational Asthma Research Program (Perelman School of Medicine) Postdoctoral Researcher – Oncology (University of Oxford) Assistant, Associate or Full Professor Position(s) – Asthma Research (University of Pennsylvania) NIH Training Grant – Pediatric Pulmonary Medicine (University of Pittsburgh) Postdoctoral Research Associate – Chronic Lung Disease (Washington University St. Louis) Faculty Position – Cancer Biology (Wake Forest School of Medicine) Assistant Professor/Postdoctoral Research Fellow – Lung Injury and Repair (University of Tennessee) Postdoctoral Opportunity – RNA and Cancer Biology (Yale University) PhD Student – Asthma Research (Karolinska Institute)
Recruit Top Talent: Reach potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
|
|
|
Have we missed an important article or publication in Pulmonary Cell News? Click here to submit! Comments or suggestions? Submit your feedback here. |
|
|

Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell News


